Rosemont Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ROSEMONT PHARMS
ROSEMONT PHARMS has two approved drugs.
There are two US patents protecting ROSEMONT PHARMS drugs.
Summary for Rosemont Pharms
| US Patents: | 2 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Rosemont Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rosemont Pharms | ATMEKSI | methocarbamol | SUSPENSION;ORAL | 219843-001 | Jul 30, 2025 | RX | Yes | Yes | 12,390,439 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Rosemont Pharms | VOSTALLY | ramipril | SOLUTION;ORAL | 219757-001 | Jul 23, 2025 | DISCN | Yes | No | 12,343,338 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Rosemont Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| United Kingdom | 2591389 | ⤷ Start Trial |
| United Kingdom | 202416818 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2020039262 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Rosemont Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0265685 | 99C0001 | Belgium | ⤷ Start Trial | PRODUCT NAME: FELODIPINUM + RAMIPRILUM; NATL. REGISTRATION NO/DATE: 354 IS 373 F 3 19981103; FIRST REGISTRATION: SE 13597 19970919 |
| 0265685 | C980030 | Netherlands | ⤷ Start Trial | PRODUCT NAME: FELODIPINE, DESGEWENST IN DE VORM VAN FYSIOLOGISCH AANVAARDBAAR ZOUT, EN (2S, 3AS, 6AS)-1-[(S)-N-[(S)-1-CARBOXY-3-FENYLPROPYL]A LANYL]OCTAHYDROCYCLOPENTA[B]-PYRROOL-2-CARBONZUUR (RAMIPRILAAT) , DESGEWENST IN DE VORM VAN EEN .....ZIE VERDER IN HET DOSSIER; NAT. REGISTRATION NO/ DATE: RVG 22449, RVG 22450 19980618; FIRST REGISTRATION: SE 13596, 13597 19970919 |
| 0265685 | SPC/GB98/047 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: COMBINATIONS OF RAMIPRIL, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, AND FELODIPINE, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF.; REGISTERED: SE 13596 19970919; SE 13597 19970919; UK 00017/0402 19980825; UK 00017/0403 19980825 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
